Annick Schatteman

Annick Schatteman possesses extensive experience in medical affairs, particularly in the fields of immunology and cardiovascular health. Since July 2020, Annick has served as the Global Medical Immunology Lead for axSpA and as the Medical Governance Lead for the Benelux region at UCB, facilitating representation of the country medical functions to various stakeholders. Prior to this role, Annick held various positions at Pfizer, including Senior Medical Advisor for Internal Medicine/Cardiovascular, where responsibilities encompassed late development and medical planning for cardiovascular portfolios, and Senior Medical Manager for Belgian operations. Annick's career also includes significant contributions at Eli Lilly and Company, spanning nearly two decades in diverse roles involving clinical research and medical affairs in cardiovascular health. Academic qualifications include a Master’s degree in Pharmacy from KU Leuven and further studies at Ichec Brussels Management School.